In October, Eli Lillys Zepbound and Mounjaro were removed from the drug shortage list after nearly two years, though the FDA warned that there still may be intermittent localized supply disruptions. The removal from the listwhich bars outsourcing facilities from producing compounded versionsspurred the Outsourcing Facilities Association to file a lawsuit against the FDA, saying the move will deprive much of the public of access to a needed medicine. In response, the FDA agreed to reevaluate the situation and will allow compounding to continue during this period
Identification of antidepressant constituents from Xiangfu-chuanxiong herbal medicine pair via spectrum-effect relationship analyses, molecular docking and corticosterone-induced PC12 cells
Pharmaceutical spending overall has grown significantly in recent years, but it has accelerated since semaglutide earned approval for chronic weight management in 2021
Bollywood actresss sudden death reignites Indias quick-fix beauty treatment debate The death of Shefali Jariwala, 42, a user of anti-ageing injections, has raised concerns about cosmetic treatment safety and heart-related deaths among young adults Jariwala, 42, died last week at her Mumbai residence after a suspected massive cardiac arrest
This is why gradual dose escalation is recommended and why dose reduction can be an effective management strategy
